杂志简称：parasite immunol
中文译名：《寄生虫免疫学》
收录属性：scie（2024版）, 目次收录（维普）,英文期刊,
自引率：5.30%
投稿方向：医学、immunology 免疫学、parasitology 寄生虫学
SCI/E期刊基本信息
出版周期：月刊 地区：英国
中科院分区：4区
是否TOP：非TOP期刊
是否综述：非综述期刊
是否OA：非OA期刊
国际标准刊号：ISSN 0141-9838；EISSN1365-3024
杂志语言：英语
出版国家：英国
杂志官网 联系方式
出版地址：111 RIVER ST,HOBOKEN,USA,NJ,07030-5774
杂志邮箱：
投稿网址：http://mc.manuscriptcentral.com/pim
杂志官方网址：https://onlinelibrary.wiley.com/journal/13653024
出版商网址：http://www.wiley.com/WileyCDA/
杂志投稿要求
投稿须知【杂志社官方网站信息】
Author Guidelines
1. SUBMISSION
Thank you for your interest in Parasite Immunology. Note that submission implies that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium.
Once you have prepared your submission in accordance with the Guidelines, manuscripts should be submitted online at https://mc.manuscriptcentral.com/pim
The submission system will prompt you to use an ORCID iD (a unique author identifier) to help distinguish your work from that of other researchers. Click here to find out more.
Click here for more details on how to use ScholarOne
Data protection:
By submitting a manuscript to or reviewing for this publication, your name, email address, and affiliation, and other contact details the publication might require, will be used for the regular operations of the publication, including, when necessary, sharing with the publisher (Wiley) and partners for production and publication. The publication and the publisher recognise the importance of protecting the personal information collected from users in the operation of these services, and have practices in place to ensure that steps are taken to maintain the security, integrity, and privacy of the personal data collected and processed. You can learn more at https://authorservices.wiley.com/statements/data-protection-policy.html.
Preprint Policy:
Wiley believes that journals publishing for communities with established pre-print servers should allow authors to submit manuscripts which have already been made available on a non-commercial preprint server. Allowing submission does not, of course, guarantee that an article will be sent out for review. It simply reflects our belief that journals should not rule out reviewing a paper simply because it has already been available on a non-commercial server. Please see below for the specific policy language.
However, Wiley also knows that the use of preprint servers is not universally accepted and that individual journals and/or societies may approach submission of preprints differently.
This journal will consider for review articles previously available as preprints on non-commercial servers such as ArXiv, bioRxiv, psyArXiv, SocArXiv, engrXiv, etc. Authors may also post the submitted version of a manuscript to non-commercial servers at any time. Authors are requested to update any pre-publication versions with a link to the final published article.
For help with submissions, please contact: pimedoffice@wiley.com
We look forward to your submission.
2. AIMS AND SCOPE
Parasite Immunology is an international journal devoted to research on all aspects of parasite immunology in humans and animals. The Journal welcomes original work on all eukaryotic infections including helminths, protozoa, fungi, ectoparasites and disease vectors. The Journal publishes studies designed to understand how hosts and vectors control parasites, the immunopathological reactions which take place in the course of parasitic infections, and the use of immunological parameters to diagnose infection to understand the distribution and transmission of parasites (immunoepidemiology). In silico studies using existing data sets to explore novel hypotheses will be considered for publication but emergent hypotheses will normally require some form of empirical validation. The global readership of Parasite Immunology includes researchers, university and college lecturers and their students, clinicians and public health professionals.
Each issue will contain original papers, brief definitive reports and review articles.
• Negative/null results
In order for research to advance, negative results, which often make a valuable contribution to the field, should be published. However, articles containing negative or null results are frequently not considered for publication or rejected by journals. We welcome papers of this kind, where appropriate and valid power calculations are included that give confidence that a negative result can be relied upon.
Keywords: parasite immunology, cellular immunology, fungus, fungal infection, helminth, helminthic disease, immunology, immunopathology, parasite, parasitology, protozoa, protozoan disease, ectoparasite, diagnosis, epidemiology
3. MANUSCRIPT CATEGORIES AND REQUIREMENTS
• Original Articles –reports of new research findings or conceptual analyses that make a significant contribution to knowledge (3500 word limit).
• Review Articles – critical reviews of the literature, including systematic reviews and meta-analyses (5000 word limit).
• Brief Reports- preliminary findings of research in progress or a case report of particular interest (1500 word limit).
• Letters to the Editor–are welcomed (400 word limit).
Please follow the recommended file formats listed here (see final paragraph). A separate figure legend should not be submitted. The majority of the accepted submissions will be published in the online issue of the journal. The editors may select the image to appear in communication platforms of the journal.
4. PREPARING YOUR SUBMISSION
Free format submission
Parasite Immunology offers free format submission for a simplified and streamlined submission process.
Before you submit, you will need:
Your manuscript: this can be a single file including text, figures, and tables, or separate files – whichever you prefer. All required sections should be contained in your manuscript, including abstract, introduction, methods, results, and conclusions. Figures and tables should have legends. References may be submitted in any style or format, as long as it is consistent throughout the manuscript. If the manuscript, figures or tables are difficult for you to read, they will also be difficult for the editors and reviewers.
The title page of the manuscript should include statements detailing any ethical procedures followed during the research, such as patient consent, ethical approval and clinical trial registration.
To submit, login at https://mc.manuscriptcentral.com/pim and create a new submission. Follow the submission steps as required and submit the manuscript.
If you are invited to revise your manuscript after peer review, the journal will request the revised manuscript to be formatted according to journal requirements as described below.
Parts of the Manuscript
The manuscript should be submitted in separate files: main text file; figures and tables.
Main Text File
The text file should be presented in the following order:
i. Title
ii. A short running title of less than 40 characters
iii. The full names of the authors
iv. The author's institutional affiliations where the work was carried out, with a footnote for the author’s present address if different from where the work was carried out
v. Conflict of interest statement
vi. Funding statement
vii. Data availability statement
viii. Author contributions
ix. Abstract and keywords
x. Main text
xi. Acknowledgements
xii. References
xiii. Tables (each table complete with title and footnotes)
xiv. Figure legends
xv. Appendices (if relevant). Figures and supporting information should be supplied as separate files
Title
The title should be short and informative, containing major keywords related to the content. The title should not contain abbreviations (see Wiley's best practice SEO tips).
Authorship
For details on eligibility for author listing, please refer to the journal’s Authorship policy outlined in the Editorial Policies and Ethical Considerations section.
Conflict of Interest Statement
Authors will be asked to provide a conflict of interest statement during the submission process. See ‘Conflict of Interest’ section in Editorial Policies and Ethical Considerations for details on what to include in this section. Authors should ensure they liaise with all co-authors to confirm agreement with the final statement.
Funding Statement
See ‘Funding’ section in Editorial Policies and Ethical Considerations for details on what to include in this section.
Data availability statement
See 'Data Sharing and Data Accessibility' section in Editorial Policies and Ethical Considerations for details on publishing your data availability statement to confirm the presence or absence of shared data.
Author contributions
Include a brief Author Contributions statement in which you describe each author's specific contributions to the work.
Abstract
The Abstract should be divided into the following sections 'Aims', 'Methods and results' and 'Conclusion'; it should not exceed 200 words.
Keywords
Please provide seven keywords. Keywords should be taken from those recommended by the US National Library of Medicine's Medical Subject Headings (MeSH) browser list at https://www.nlm.nih.gov/mesh/.
Main text Following the abstract, the main section should consist of these sections: Introduction, Materials and Methods, Results, Discussion. Pages should be numbered consecutively in arabic numerals. Please also ensure that the lines in your manuscript are numbered.
Acknowledgements
Contributions from individuals who do not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgements section. Financial and material support should also be mentioned. Thanks to anonymous reviewers are not appropriate.
References
References should be in Vancouver format and numbered consecutively in order of appearance. In text citations should cite references in consecutive order using Arabic superscript numerals and should be listed numerically in the reference list at the end of the article.
Format references as below, using standard (Medline) abbreviations for journal titles. If more than six authors, include the first three authors followed by et al.
Sample references follow:
Journal article
1. King VM, Armstrong DM, Apps R, Trott JR. Numerical aspects of pontine, lateral reticular, and inferior olivary projections to two paravermal cortical zones of the cat cerebellum. J Comp Neurol 1998;390:537-551.
Book
2. Voet D, Voet JG. Biochemistry. New York: John Wiley & Sons; 1990. 1223 p. Please note that journal title abbreviations should conform to the practices of Chemical Abstracts.
Internet Document
9. American Cancer Society. Cancer Facts & Figures 2003. http://www.cancer.org/downloads/STT/CAFF2003PWSecured.pdf. Accessed March 3, 2003.
Tables
Tables should be self-contained and complement, but not duplicate, information contained in the text. They should be supplied as editable files, not pasted as images. Legends should be concise but comprehensive – the table, legend and footnotes must be understandable without reference to the text. All abbreviations must be defined in footnotes. Footnote symbols: †, ‡, §, ¶, should be used (in that order) and *, **, *** should be reserved for P-values. Statistical measures such as SD or SEM should be identified in the headings.
Figure Legends
Legends should be concise but comprehensive – the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement.
Preparing Figures
Although we encourage authors to send us the highest-quality figures possible, for peer-review purposes we are happy to accept a wide variety of formats, sizes, and resolutions.
Click here for the basic figure requirements for figures submitted with manuscripts for initial peer review, as well as the more detailed post-acceptance figure requirements.
Colour figures
Figures submitted in colour may be reproduced in colour online free of charge.
Appendices
Appendices will be published after the references. For submission they should be supplied as separate files but referred to in the text.
Supporting Information
Supporting information is information that is not essential to the article but that provides greater depth and background. It is hosted online, and appears without editing or typesetting. It may include tables, figures, videos, datasets, etc. Click here for Wiley’s FAQs on supporting information. Note, if data, scripts or other artefacts used to generate the analyses presented in the paper are available via a publicly available data repository, authors should include a reference to the location of the material within their paper.
General Style Points
The following links provide general advice on formatting and style.
• Abbreviations: In general, terms should not be abbreviated unless they are used repeatedly and the abbreviation is helpful to the reader. Initially use the word in full, followed by the abbreviation in parentheses. Thereafter use the abbreviation only.
• Units of measurement: Measurements should be given in SI or SI-derived units. Visit the Bureau International des Poids et Mesures (BIPM) website at http://www.bipm.fr for more information about SI units.
• Numbers: numbers under 10 are spelt out, except for: measurements with a unit (8mmol/l); age (6 weeks old), or lists with other numbers (11 dogs, 9 cats, 4 gerbils).
• Trade Names: Chemical substances should be referred to by the generic name only. Trade names should not be used. Drugs should be referred to by their generic names. If proprietary drugs have been used in the study, refer to these by their generic name, mentioning the proprietary name, and the name and location of the manufacturer, in parentheses.
• Human and Murine Genes: For human genes, use genetic notation and symbols approved by the HUGO Nomenclature Committee. Approved gene symbols should be obtained prior to submission from the HUGO Nomenclature Committee, nome@galton.ucl.ac.uk. For nomenclature guidelines, see White et al., 'Guidelines for Human Gene Nomenclature' [Genomics, 45, 468-471 (1997)]. The Gene Name Proposal form may be completed on the Nomenclature Web page: http://www.genenames.org. Use ISCN nomenclature for cytogenetics notation [Mitelman, F. (ed.) ISCN 1995: An International System for Human Cytogenetic Nomenclature, S. Karger, Basel]. Human gene names and loci should be written in uppercase italics and Arabic numerals. Protein products are not italicized. For mouse strain and genetic nomenclature, refer to the International Committee on Standardized Genetic Nomenclature for Mice: http://www.informatics.jax.org/nomen/. New symbols and names for genes should be obtained prior to submission through the online symbol registry form at: http://www.informatics.jax.org/nomen/nomen-submit-form.shtml.